Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E97.04 EPS (ttm)0.52 Insider Own0.50% Shs Outstand2.62B Perf Week1.70%
Market Cap131.65B Forward P/E19.61 EPS next Y2.56 Insider Trans0.00% Shs Float2.60B Perf Month-0.56%
Income1.34B PEG5.55 EPS next Q0.43 Inst Own18.40% Short Float0.16% Perf Quarter5.24%
Sales24.38B P/S5.40 EPS this Y-9.60% Inst Trans-2.18% Short Ratio1.45 Perf Half Y10.46%
Book/sh4.64 P/B10.81 EPS next Y23.87% ROA3.60% Target Price53.05 Perf Year24.09%
Cash/sh1.82 P/C27.54 EPS next 5Y17.50% ROE18.00% 52W Range36.83 - 51.55 Perf YTD0.62%
Dividend1.40 P/FCF- EPS past 5Y-3.60% ROI10.90% 52W High-2.68% Beta0.51
Dividend %2.79% Quick Ratio0.70 Sales past 5Y-3.10% Gross Margin80.10% 52W Low36.21% ATR0.83
Employees64400 Current Ratio0.90 Sales Q/Q20.00% Oper. Margin14.40% RSI (14)54.28 Volatility1.26% 1.21%
OptionableYes Debt/Eq1.49 EPS Q/Q-33.00% Profit Margin9.00% Rel Volume1.47 Prev Close48.94
ShortableYes LT Debt/Eq1.45 EarningsFeb 14 BMO Payout161.60% Avg Volume2.78M Price50.17
Recom1.50 SMA201.80% SMA501.24% SMA20011.95% Volume4,080,939 Change2.51%
Nov-22-19Initiated SVB Leerink Outperform
Oct-25-19Upgrade Liberum Hold → Buy
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-23-20 02:08AM  Why It Might Not Make Sense To Buy AstraZeneca PLC (LON:AZN) For Its Upcoming Dividend Simply Wall St.
Feb-21-20 04:58PM  Top Stock Reports for Visa, JPMorgan & Bank of America Zacks
10:03AM  Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval Zacks
Feb-19-20 03:00AM  NeoTX Closes $45 Million Series C Financing GlobeNewswire
Feb-14-20 04:37PM  AstraZeneca Stock Dives As Coronavirus Expected To Batter 2020 Results Investor's Business Daily
11:41AM  Risks Remain, but Amarin Stock Is a Buy at Todays Prices InvestorPlace
09:38AM  AstraZeneca Warns of Coronavirus Impact and Profits Tumble. The Stock Is Falling. Barrons.com
09:21AM  AstraZeneca's (AZN) Q4 Earnings and Sales Miss Estimates Zacks
08:13AM  GLOBAL MARKETS-European stocks climb to record on hopes of limited coronavirus economic hit Reuters
07:13AM  GLOBAL MARKETS-European shares hit record even as coronavirus shows no signs of peaking Reuters
05:38AM  AstraZeneca Cautions on Coronavirus Impact, But Sees Solid 2020 Revenue Growth TheStreet.com
05:32AM  European Stocks Are Going Nowhere as Investors Gauge COVID-19 and Gloomy German Growth Barrons.com
04:39AM  AstraZeneca braces for coronavirus hit, but no impact so far Reuters
04:20AM  MORNING BID EUROPE-Virus victim count rises -- and so do global stocks Reuters
04:09AM  GLOBAL MARKETS-European shares scale record even as coronavirus shows no signs of peaking Reuters
03:19AM  AstraZeneca warns of unfavourable coronavirus impact Financial Times
02:56AM  AstraZeneca operating profit misses forecasts and warns outlook hinges on COVID-19 MarketWatch
Feb-12-20 08:00PM  RPT-FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials Reuters
12:27PM  FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials Reuters
09:45AM  FibroGen's (FGEN) NDA for Roxadustat Accepted by the FDA Zacks
08:51AM  Antigua Bidco Limited -- Moody's affirms Atnahs' B2 ratings; outlook stable Moody's
Feb-11-20 05:00PM  FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease GlobeNewswire
09:00AM  What's in Store for AstraZeneca (AZN) This Earnings Season? Zacks
Feb-10-20 10:13AM  What's in Store for Ironwood (IRWD) This Earnings Season? Zacks
Feb-06-20 10:51AM  Allergan (AGN) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-05-20 04:34PM  Merck Stock Dives As Revenue Lags; Dow Jones Giant Plans Spinoff Investor's Business Daily
09:47AM  Merck (MRK) Beats on Q4 Earnings, Plans Women Health Spin Off Zacks
Feb-04-20 12:22PM  3 UK Charts to Watch Investopedia
Feb-03-20 06:54AM  Merck (MRK) to Report Q4 Earnings: Is a Beat in the Offing? Zacks
Feb-02-20 04:06PM  A Trio of High-Yield Stocks for the Dividend Investor GuruFocus.com
Jan-31-20 10:32AM  Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative Zacks
Jan-30-20 01:22PM  Delco company tops Forbes list of best employers for diversity American City Business Journals
09:00AM  Educational Lung Cancer Event Coming to The Villages to Raise Awareness of the States High Rate of Lung Cancer Business Wire
02:00AM  INSIGHT-On eve of Brexit, Britain faces critical test to defend drug trial crown Reuters
Jan-28-20 10:52AM  Allergan to Divest Brazikumab, Zenpep to Close AbbVie Merger Zacks
03:55AM  Read This Before Selling AstraZeneca PLC (LON:AZN) Shares Simply Wall St.
Jan-27-20 09:41AM  Allergan to divest two drugs, to move forward with AbbVie deal MarketWatch
07:00AM  BRILINTA Met Primary Endpoint in the Phase III THALES Trial in Stroke Business Wire
05:04AM  Allergan Sells Drugs to Nestle and AstraZeneca Ahead of AbbVie Tie-Up TheStreet.com
04:26AM  AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys Reuters
01:15AM  AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep PR Newswire
Jan-24-20 11:01AM  Cheplapharm Arzneimittel GmbH -- Moody's affirms Cheplapharm's B2 rating, outlook stable Moody's
10:52AM  Roche's Urothelial Cancer Study on Tecentriq Disappoints Zacks
09:54AM  Pharma Stock Roundup: J&J's Mixed Q4, Roche & Novartis' New Drugs Approval in EU Zacks
07:00AM  Genprex: The Bad and the Good of Capital Raises TheStreet.com
Jan-23-20 01:02PM  13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak Benzinga
08:46AM  Pfizer (PFE) Q4 Earnings Coming Up: What's in the Cards? Zacks
Jan-22-20 02:28PM  Health stocks reverse coronavirus gains as one analyst says the market is overreacting Yahoo Finance
10:54AM  Genprex's stock rallies on FDA fast-track designation MarketWatch
10:03AM  Roche wins approval for cancer drug Kadcyla in fast-growing China market Reuters
09:20AM  5 Big Drug/Biotech Stocks Set to Trump Q4 Earnings Estimates Zacks
Jan-21-20 12:53PM  Top Stock Research Reports for Roche, Royal Dutch Shell & Citigroup Zacks
07:05AM  Myriad Submits sPMA for BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Metastatic Castration-resistant Prostate Cancer GlobeNewswire
Jan-20-20 11:40AM  BMY or AZN: Which Is the Better Value Stock Right Now? Zacks
09:03AM  AstraZeneca Announces Positive FDA Updates on Cancer Drugs Zacks
04:00AM  Japan, U.S. lead survey's corporate climate change action 'A List' Reuters
02:17AM  RPT-JPMorgan to buy Paris building to bring euro teams from London Reuters
Jan-19-20 03:15PM  JPMorgan to buy Paris building to bring euro teams from London Reuters
Jan-18-20 02:40AM  Drugmakers slash prices to be eligible for China's bulk-buy program Reuters
Jan-17-20 11:07AM  Does Acasti Stock Have a Future? InvestorPlace
08:11AM  Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates Zacks
06:30AM  Why Amarin Stock Is Poised for a Healthy 2020 InvestorPlace
Jan-16-20 09:09AM  Clovis Rubraca sNDA for Prostate Cancer Gets Priority Review Zacks
Jan-14-20 03:12PM  Eli Lilly ends deal with NextCure worth up to $1.4B for the local biotech American City Business Journals
03:09PM  3 Gaithersburg biotech buildings sell for $53.25M American City Business Journals
09:46AM  AstraZeneca to End Phase III Study on Fish Oil Heart Drug Zacks
Jan-13-20 04:22PM  This Biotech Stock Is Flying High After Rival Heart Drugs Stumbled Investor's Business Daily
02:31PM  Amarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint MarketWatch
11:07AM  Amarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall Short Barrons.com
10:03AM  AstraZeneca plc (AZN) vs. Top 20 Hedge Fund Stocks in 2019 Insider Monkey
09:40AM  This Biotech Stock Is Flying High After Rival Heart Drugs Stumbled Investor's Business Daily
07:49AM  AstraZeneca takes $100m hit after failed heart drug trial Financial Times
07:40AM  AstraZeneca Abandons Fish Oil Pill for Bad Cholesterol Bloomberg
02:27AM  AstraZeneca to discontinue Epanova trial following disappointing data MarketWatch
Jan-10-20 10:59AM  All Bets Are Off for Amarin Stock InvestorPlace
Jan-08-20 12:00PM  Spiros Segalas Adds 4 Stocks to Portfolio in 4th Quarter GuruFocus.com
08:13AM  3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020 Zacks
Jan-07-20 09:42AM  Pfizer/Merck KGaA's Bavencio Positive in Bladder Cancer Study Zacks
07:26AM  Why Bank of America expects the hot European pharmaceuticals sector to stumble and its not a fear of U.S. drug prices MarketWatch
Jan-06-20 04:13PM  One Analyst Thinks AbbVie Is Grossly Undervalued GuruFocus.com
10:21AM  Buy Sanofi Stock Because Its Undervalued, J.P. Morgan Says Barrons.com
09:44AM  AstraZeneca's Farxiga sNDA Gets Priority Review Status by FDA Zacks
07:00AM  FARXIGA Granted FDA Priority Review For Patients With Heart Failure With Reduced Ejection Fraction Business Wire
Jan-03-20 11:40AM  BMY or AZN: Which Is the Better Value Stock Right Now? Zacks
10:54AM  Innate Pharma's Filing for Leukemia Drug Accepted in Europe Zacks
09:58AM  Horizon Therapeutics' Stock Up in a Year on Pipeline Progress Zacks
06:00AM  Amarin Risks Getting Exposed as a Paper Tiger InvestorPlace
Jan-02-20 11:53AM  Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward GuruFocus.com
09:35AM  5 Reasons Why Ironwood Stock Should Be in Your Portfolio Zacks
08:53AM  Innate Pharma's stock rallies 23% on leukemia drug submission in Europe MarketWatch
12:55AM  A Note On AstraZeneca PLC's (LON:AZN) ROE and Debt To Equity Simply Wall St.
Dec-31-19 12:01PM  Vascepas Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock InvestorPlace
11:12AM  Myriad Genetics' Cancer Companion Diagnostic Test Gets FDA Nod Zacks
08:55AM  AstraZeneca's Lynparza Gets FDA Nod for Pancreatic Cancer Zacks
Dec-30-19 04:08PM  This Genetic-Testing Stock Popped, Then Slipped, On Its FDA Approval Investor's Business Daily
02:43PM  Merck-AstraZeneca's Lynparza Snags FDA Nod For Pancreatic Cancer Benzinga
11:06AM  AstraZeneca and Merck Get a Boost as FDA Approves New Use for Cancer Drug Barrons.com
07:45AM  Myriad Genetics's stock surges after FDA approval of diagnostic test for pancreatic cancer MarketWatch
07:05AM  Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza® (olaparib) In Patients with Germline BRCA-mutated Metastatic Pancreatic Cancer GlobeNewswire
06:55AM  LYNPARZA (Olaparib) Approved in the US as a 1st-line Maintenance Treatment of Germline BRCA-mutated Metastatic Pancreatic Cancer Business Wire
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a collaboration and license option agreement with Transgene SA, Ironwood Pharmaceuticals, Inc., and MiNA Therapeutics. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 07Buy19.00425,0008,075,00014,650,334Oct 09 04:53 PM